CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodesMoritz Rapp, David Anz, Maximilian W. M. Wintergerst et al.|The Journal of Experimental Medicine|2019Cited by 275
Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor ImmunityEva Sum, Pablo Umaña, Ulrike Hopfer et al.|Clinical Cancer Research|2021Cited by 70
Supplementary Figures 1-6 from Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor ImmunityEva Sum, Pablo Umaña, Moritz Rapp et al.|Unknown|2023Cited by 0
Supplementary Table 1 from Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor ImmunityEva Sum, Pablo Umaña, Moritz Rapp et al.|Unknown|2023Cited by 0
Supplementary Table 2 from Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor ImmunityEva Sum, Pablo Umaña, Moritz Rapp et al.|Unknown|2023Cited by 0